Sivan is a start-up company focusing on the development of innovative digital tools for the health industry.
Thanks to its strong scientific evidence and clinical expertise, Sivan developed Moovcare®, a medical application for early detection of relapses and complications in the follow-up process of patients with lung cancer. Moovcare® was proven in a clinical study to improve survival and QOL.
Thanks to Moovcare®, patients have constant communication with their physician, problems are detected earlier, and oncologists are giving the right treatment at the right time. Moovcare® supports healthcare professionals in their practice, saves cost to the health system. Satisfaction study showed 98 % satisfaction among patients using Moovcare.
It is the first DTX officially reimbursed in France.